Global Stereotactic Surgery Devices Market Size and Forecast to 2029: Revenue, Growth, and Trends

Global Stereotactic Surgery Devices Market

Uncover key drivers, emerging technologies, and competitive movements shaping the stereotactic surgery devices market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Stereotactic Surgery Devices Market Size Today And What Will Its Value Be At The End Of 2029?

The stereotactic surgery devices market size has experienced consistent expansion in recent years. This market is projected to expand from $21.8 billion in 2024 to $22.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 2.9%. Historically, this growth has been driven by factors such as a move towards less invasive medical procedures, the incorporation of robotics and automation, a heightened need for exactness and precision, and enhanced safety characteristics.

The stereotactic surgery devices market is poised for robust expansion in the upcoming years. Its valuation is predicted to reach $28.84 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is primarily driven by an increase in cancer incidences, the integration of AI and machine learning, an broadening into new medical specializations, the rising elderly demographic, and the customization and personalization of therapies. Significant developments expected within this timeframe encompass improvements in precision and accuracy, the miniaturization of equipment, the adoption of robotics and automation, the evolution of personalized treatment strategies, and the expansion of applications and procedural methods.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp

Which Key Drivers Are Powering Growth In The Stereotactic Surgery Devices Market?

The anticipated expansion of the stereotactic surgical device market is propelled by a rising prevalence of Parkinson’s disease and epilepsy. Parkinson’s disease manifests as a neurodegenerative condition characterized by involuntary tremors, slowed movements, and muscle rigidity, while epilepsy is a neurological disorder impacting the brain, making individuals prone to recurrent, unprovoked seizures. These stereotactic surgical devices find application in managing various conditions, including movement disorders, epilepsy, chronic pain, psychiatric conditions, and specifically Parkinson’s disease. For example, according to research from the Parkinson’s Foundation, a New York-based national nonprofit organization, more than 90,000 individuals in the United States are projected to receive a Parkinson’s disease diagnosis annually in 2022. This represents a 50% rise compared to the earlier projected yearly incidence of 60,000 diagnoses. Currently, Parkinson’s disease impacts almost a million individuals in the United States, with projections indicating an increase to 1.2 million by 2030. Consequently, the expanding incidence of Parkinson’s disease and epilepsy serves as a primary driver for the growth of the stereotactic surgical device market.

Which Segment Categories Are Driving Maximum Growth In The Stereotactic Surgery Devices Market?

The stereotactic surgery devicesmarket covered in this report is segmented –

1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife

2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications

3) By End User: Hospitals, Laboratories

Subsegments:

1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon

2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC

3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems

4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System

What Key Trends Are Driving Growth In The Stereotactic Surgery Devices Market?

Technological advancements are emerging as the principal trend gaining traction in the stereotactic surgical device market. Leading companies operating within this market are developing innovative technologies to strengthen their competitive standing. For instance, in May 2023, Brainlab, a Germany-based medical technology company, launched ExacTrac Dynamic Surface, a new surface guided radiation therapy (SGRT) system for patient tracking and positioning. This system features high-speed thermal surface tracking technology combined with an update to ExacTrac X-ray monitoring, enhancing versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system emits a structured blue light pattern onto the patient surface, which is acquired by two 3D cameras, and each surface point is augmented with a thermal signature, registered by the third in-unit camera.

Who Are The Leading Companies Driving The Stereotactic Surgery Devices Market?

Major companies operating in the stereotactic surgery devices market include Alliance Oncology, Micromar Industria Commercio Ltda., Adeor Medical AG, Monteris Medical Holding AG, Inomed Medizintechnik GmbH, Ion Beam Applications S.A. (IBA), Elekta AB (publ), Varian Medical Systems Inc., Accuracy Incorporated, Modus Medical Devices Inc., Koninklijke Philips N.V., Huiheng Group Co. Ltd., Mitsubishi Heavy Industries Ltd., GE Healthcare, Siemens AG, Medtronic plc, Brainlab AG, Renishaw plc, Neuropace Inc., Microvention Inc., MR Solutions Ltd., RaySearch Laboratories AB, Alpha Omega Engineering Inc., FHC Inc., Nexstim Plc, Scopis GmbH, IZI Medical Products LLC, Integra LifeSciences Holdings Corporation, Computerized Imaging Reference Systems Inc., MRI Interventions Inc., ZAP Surgical Systems Inc., Schaerer Medical USA Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report

Which Region Holds The Largest Share In The Stereotactic Surgery Devices Market Today?

North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10495&type=smp

Browse Through More Reports Similar to the Global Stereotactic Surgery Devices Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model